Compare Strategy Inc. (MSTR) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Nuvalent Inc — how do they compare? Strategy Inc. trades at $101.9 (market cap $35.47B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: Strategy Inc. is far larger — about 3.6× Nuvalent Inc's market cap, and Nuvalent Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| MSTR | NUVL | |
|---|---|---|
Market Cap | $35.47B | $9.81B |
Sector | Technology | Technology |
52-Week High | $426.40 | $123.96 |
52-Week Low | $82.31 | $72.16 |
Enterprise Value | $50.50B | $8.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
